Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Docgo Inc. (DCGO) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Docgo Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1822359.
Total stock buying since 2022: $368,740.
Total stock sales since 2022: $4,040,970.
Total stock option exercises since 2022: $1,610,562.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 70,000 | $103,350 | 0 | $0 | 0 | $0 |
| 2024 | 78,500 | $265,390 | 39,588 | $174,120 | 0 | $0 |
| 2023 | 0 | $0 | 426,651 | $3,866,850 | 92,305 | $100,119 |
| 2022 | 0 | $0 | 0 | $0 | 661,273 | $1,510,443 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 70,000 | $103,350 | 0 | $0 | 0 | $0 |
| 2024-12 | 0 | $0 | 39,588 | $174,120 | 0 | $0 |
| 2024-05 | 45,000 | $144,050 | 0 | $0 | 0 | $0 |
| 2024-03 | 33,500 | $121,340 | 0 | $0 | 0 | $0 |
| 2023-12 | 0 | $0 | 0 | $0 | 46,176 | $0 |
| 2023-11 | 0 | $0 | 2,859 | $16,439 | 0 | $0 |
| 2023-10 | 0 | $0 | 11,667 | $62,718 | 10,000 | $15,900 |
| 2023-09 | 0 | $0 | 13,667 | $87,635 | 10,000 | $15,900 |
| 2023-08 | 0 | $0 | 139,029 | $1,411,369 | 10,000 | $15,900 |
| 2023-06 | 0 | $0 | 47,897 | $436,747 | 0 | $0 |
| 2023-05 | 0 | $0 | 211,532 | $1,851,942 | 16,129 | $52,419 |
| 2022-07 | 0 | $0 | 0 | $0 | 645,145 | $1,458,027 |
| 2022-04 | 0 | $0 | 0 | $0 | 16,128 | $52,416 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-15 | Burdiek Michael J | Buy | 15,000 | 1.43 | 21,450 |
| 2025-05-14 | Bienstock Lee (Chief Executive Officer) | Buy | 15,000 | 1.54 | 23,100 |
| 2025-05-14 | Sugrue Stephen (Chief Compliance Officer) | Buy | 10,000 | 1.44 | 14,400 |
| 2025-05-14 | Rosenberg Norman (CFO and Treasurer) | Buy | 15,000 | 1.47 | 22,050 |
| 2025-05-14 | Klasko Stephen K. M.d. (Director) | Buy | 15,000 | 1.49 | 22,350 |
| 2024-12-17 | Leite Etalvina | Sale | 16,500 | 4.34 | 71,610 |
| 2024-12-16 | Tendler Ely D (General Counsel and Secretary) | Sale | 23,088 | 4.44 | 102,510 |
| 2024-05-14 | Burdiek Michael J | Buy | 10,000 | 3.40 | 34,000 |
| 2024-05-13 | Bienstock Lee (Chief Executive Officer) | Buy | 25,000 | 3.15 | 78,750 |
| 2024-05-13 | Tendler Ely D (General Counsel and Secretary) | Buy | 10,000 | 3.13 | 31,300 |
| 2024-03-15 | Katz Steven | Buy | 13,500 | 3.64 | 49,140 |
| 2024-03-14 | Rosenberg Norman (CFO and Treasurer) | Buy | 10,000 | 3.61 | 36,100 |
| 2024-03-14 | Burdiek Michael J | Buy | 10,000 | 3.61 | 36,100 |
| 2023-12-15 | Burdiek Michael J | Option Ex | 23,088 | .00 | 0 |
| 2023-12-15 | Travers James M | Option Ex | 23,088 | .00 | 0 |
| 2023-11-28 | Sugrue Stephen (Chief Compliance Officer) | Sale | 2,859 | 5.75 | 16,439 |
| 2023-10-16 | Bienstock Lee (Chief Executive Officer) | Sale | 1,667 | 5.89 | 9,818 |
| 2023-10-02 | Tendler Ely D (General Counsel and Secretary) | Sale | 10,000 | 5.29 | 52,900 |
| 2023-10-02 | Tendler Ely D (General Counsel and Secretary) | Option Ex | 10,000 | 1.59 | 15,900 |
| 2023-09-15 | Bienstock Lee (Chief Executive Officer) | Sale | 1,667 | 6.32 | 10,535 |
| 2023-09-15 | Tendler Ely D (General Counsel and Secretary) | Sale | 10,000 | 5.91 | 59,100 |
| 2023-09-15 | Tendler Ely D (General Counsel and Secretary) | Option Ex | 10,000 | 1.59 | 15,900 |
| 2023-09-01 | Capone Anthony (Chief Executive Officer) | Sale | 2,000 | 9.00 | 18,000 |
| 2023-08-22 | Tendler Ely D (General Counsel and Secretary) | Sale | 10,000 | 8.75 | 87,500 |
| 2023-08-22 | Tendler Ely D (General Counsel and Secretary) | Option Ex | 10,000 | 1.59 | 15,900 |
| 2023-08-15 | Oberholzer Adriaan Stephanus (See Remarks) | Sale | 79,029 | 10.33 | 816,369 |
| 2023-08-14 | Oberholzer Adriaan Stephanus (See Remarks) | Sale | 50,000 | 10.15 | 507,500 |
| 2023-06-08 | Capone Anthony (Chief Executive Officer) | Sale | 5,400 | 9.50 | 51,300 |
| 2023-06-01 | Oberholzer Adriaan Stephanus (See Remarks) | Sale | 42,497 | 9.07 | 385,447 |
| 2023-05-31 | Oberholzer Adriaan Stephanus (See Remarks) | Sale | 22,366 | 9.01 | 201,517 |
| 2023-05-30 | Oberholzer Adriaan Stephanus (See Remarks) | Sale | 16,271 | 9.02 | 146,764 |
| 2023-05-25 | Oberholzer Adriaan Stephanus (See Remarks) | Sale | 300 | 9.07 | 2,721 |
| 2023-05-24 | Oberholzer Adriaan Stephanus (See Remarks) | Sale | 40,000 | 9.14 | 365,600 |
| 2023-05-23 | Oberholzer Adriaan Stephanus (See Remarks) | Sale | 7,595 | 9.11 | 69,190 |
| 2023-05-19 | Sugrue Stephen (Chief Compliance Officer) | Option Ex | 16,129 | 3.25 | 52,419 |
| 2023-05-17 | Travers James M | Sale | 65,000 | 8.51 | 553,150 |
| 2023-05-16 | Travers James M | Sale | 60,000 | 8.55 | 513,000 |
| 2022-07-01 | Capone Anthony (President) | Option Ex | 645,145 | 2.26 | 1,458,027 |
| 2022-04-07 | Sugrue Stephen (Chief Compliance Officer) | Option Ex | 16,128 | 3.25 | 52,416 |
Insider trading activities including stock purchases, stock sales, and option exercises of DCGO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Docgo Inc. (symbol DCGO, CIK number 1822359) see the Securities and Exchange Commission (SEC) website.